Pediatr Allergy Immunol:舌下免疫治疗能够改变梯牧草过敏儿童的唾液lgA和全身免疫调控因子

2019-03-17 AlexYang MedSci原创

舌下免疫治疗的免疫调控响应对过敏性儿童的全身和粘膜调控因子的影响仍旧大部分未知。最近,有研究人员在一个为期3年梯牧草花粉舌下免疫治疗的过敏性鼻炎儿童群体中,调查了相关的细胞因子和趋化因子水平以及lgA响应情况。研究发现,在3年的治疗后以及治疗结束2年后,GRAZAX®治疗的儿童表现出了显著更高的phl p1特异性唾液IgA和血清IgG4水平,以及显著更低的皮刺试验阳性率。另外,Th1相关的趋化因子

舌下免疫治疗的免疫调控响应对过敏性儿童的全身和粘膜调控因子的影响仍旧大部分未知。最近,有研究人员在一个为期3年梯牧草花粉舌下免疫治疗的过敏性鼻炎儿童群体中,调查了相关的细胞因子和趋化因子水平以及lgA响应情况。

研究发现,在3年的治疗后以及治疗结束2年后,GRAZAX®治疗的儿童表现出了显著更高的phl p1特异性唾液IgA和血清IgG4水平,以及显著更低的皮刺试验阳性率。另外,Th1相关的趋化因子CXCL10和CXCL11血浆水平在治疗组儿童中要比未治疗组儿童显著更高。另外,3年的积极治疗能够产生梯牧草诱导的IL-5/IL-13与IFN-γ的比例显著减少,以及过敏性鼻炎严重度和视觉模拟评分量表的减少。然而,研究人员并未发现临床结果与免疫学参数之间的一致相关性。

最后,研究人员指出,草花粉过敏性儿童的舌下白喉免疫治疗能够通过增加Th-1响应和减少Th2响应以及诱导免疫调控响应来调控口腔粘膜的免疫响应以及全身的免疫响应。

原始出处:

Huoman J, Papapavlou G, Pap A et al. Sublingual immunotherapy alters salivary IgA and systemic immune mediators in timothy allergic children. Pediatr Allergy Immunol. 25 Feb 2019.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1639013, encodeId=e2eb163901371, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Feb 17 20:02:00 CST 2020, time=2020-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1727945, encodeId=ea6d1e27945e0, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Mar 31 18:02:00 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329220, encodeId=aa7213292208b, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Tue Mar 19 03:02:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599291, encodeId=c0451599291f1, content=<a href='/topic/show?id=bfa7291e596' target=_blank style='color:#2F92EE;'>#免疫调控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29175, encryptionId=bfa7291e596, topicName=免疫调控)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f5018689307, createdName=yangcx0921, createdTime=Tue Mar 19 03:02:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=362927, encodeId=026336292e9d, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Mon Mar 18 09:07:22 CST 2019, time=2019-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=362884, encodeId=4936362884ff, content=舌下免疫治疗进展。, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Mar 17 12:13:51 CST 2019, time=2019-03-17, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1639013, encodeId=e2eb163901371, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Feb 17 20:02:00 CST 2020, time=2020-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1727945, encodeId=ea6d1e27945e0, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Mar 31 18:02:00 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329220, encodeId=aa7213292208b, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Tue Mar 19 03:02:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599291, encodeId=c0451599291f1, content=<a href='/topic/show?id=bfa7291e596' target=_blank style='color:#2F92EE;'>#免疫调控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29175, encryptionId=bfa7291e596, topicName=免疫调控)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f5018689307, createdName=yangcx0921, createdTime=Tue Mar 19 03:02:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=362927, encodeId=026336292e9d, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Mon Mar 18 09:07:22 CST 2019, time=2019-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=362884, encodeId=4936362884ff, content=舌下免疫治疗进展。, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Mar 17 12:13:51 CST 2019, time=2019-03-17, status=1, ipAttribution=)]
    2019-03-31 feather89
  3. [GetPortalCommentsPageByObjectIdResponse(id=1639013, encodeId=e2eb163901371, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Feb 17 20:02:00 CST 2020, time=2020-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1727945, encodeId=ea6d1e27945e0, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Mar 31 18:02:00 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329220, encodeId=aa7213292208b, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Tue Mar 19 03:02:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599291, encodeId=c0451599291f1, content=<a href='/topic/show?id=bfa7291e596' target=_blank style='color:#2F92EE;'>#免疫调控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29175, encryptionId=bfa7291e596, topicName=免疫调控)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f5018689307, createdName=yangcx0921, createdTime=Tue Mar 19 03:02:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=362927, encodeId=026336292e9d, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Mon Mar 18 09:07:22 CST 2019, time=2019-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=362884, encodeId=4936362884ff, content=舌下免疫治疗进展。, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Mar 17 12:13:51 CST 2019, time=2019-03-17, status=1, ipAttribution=)]
    2019-03-19 膀胱癌
  4. [GetPortalCommentsPageByObjectIdResponse(id=1639013, encodeId=e2eb163901371, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Feb 17 20:02:00 CST 2020, time=2020-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1727945, encodeId=ea6d1e27945e0, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Mar 31 18:02:00 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329220, encodeId=aa7213292208b, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Tue Mar 19 03:02:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599291, encodeId=c0451599291f1, content=<a href='/topic/show?id=bfa7291e596' target=_blank style='color:#2F92EE;'>#免疫调控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29175, encryptionId=bfa7291e596, topicName=免疫调控)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f5018689307, createdName=yangcx0921, createdTime=Tue Mar 19 03:02:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=362927, encodeId=026336292e9d, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Mon Mar 18 09:07:22 CST 2019, time=2019-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=362884, encodeId=4936362884ff, content=舌下免疫治疗进展。, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Mar 17 12:13:51 CST 2019, time=2019-03-17, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1639013, encodeId=e2eb163901371, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Feb 17 20:02:00 CST 2020, time=2020-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1727945, encodeId=ea6d1e27945e0, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Mar 31 18:02:00 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329220, encodeId=aa7213292208b, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Tue Mar 19 03:02:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599291, encodeId=c0451599291f1, content=<a href='/topic/show?id=bfa7291e596' target=_blank style='color:#2F92EE;'>#免疫调控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29175, encryptionId=bfa7291e596, topicName=免疫调控)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f5018689307, createdName=yangcx0921, createdTime=Tue Mar 19 03:02:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=362927, encodeId=026336292e9d, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Mon Mar 18 09:07:22 CST 2019, time=2019-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=362884, encodeId=4936362884ff, content=舌下免疫治疗进展。, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Mar 17 12:13:51 CST 2019, time=2019-03-17, status=1, ipAttribution=)]
    2019-03-18 smartxiuxiu

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1639013, encodeId=e2eb163901371, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Feb 17 20:02:00 CST 2020, time=2020-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1727945, encodeId=ea6d1e27945e0, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Mar 31 18:02:00 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329220, encodeId=aa7213292208b, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Tue Mar 19 03:02:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599291, encodeId=c0451599291f1, content=<a href='/topic/show?id=bfa7291e596' target=_blank style='color:#2F92EE;'>#免疫调控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29175, encryptionId=bfa7291e596, topicName=免疫调控)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f5018689307, createdName=yangcx0921, createdTime=Tue Mar 19 03:02:00 CST 2019, time=2019-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=362927, encodeId=026336292e9d, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Mon Mar 18 09:07:22 CST 2019, time=2019-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=362884, encodeId=4936362884ff, content=舌下免疫治疗进展。, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Mar 17 12:13:51 CST 2019, time=2019-03-17, status=1, ipAttribution=)]
    2019-03-17 jyzxjiangqin

    舌下免疫治疗进展。

    0

相关资讯

Indian J Pediatr:在过敏性鼻炎中,舌下免疫治疗能够减少儿童中白介素-33的表达

最近,有研究人员在患有AR(过敏性鼻炎)的儿童中鉴定了IL-33在SLIT(舌下免疫治疗)期间的表达情况。研究包括了30名对屋尘螨(HDM)过敏的儿童并且接受SLIT治疗,另外30名儿童则接受安慰剂治疗作为对照。在SLIT期间,研究人员收集了处理组和对照组不同时间点的血清和鼻腔灌洗样本,并利用酶联免疫法(ELISA)对这些样本的白介素-33和其他细胞因子进行了评估。研究人员还制备了外周血单个核细胞

Allergy Asthma Clin Immunol:5种草花粉提取混合物舌下免疫治疗的观察性群体研究

过敏性鼻炎影响着西方欧洲人口群体的四分之一之多。预防过敏源免疫疗法在减少急性症状发作(花粉过敏)中是有效的。到目前为止,一种5种草花粉提取混合物舌下免疫治疗(5GPE-SLIT)被用来治疗花粉过敏的过敏性鼻炎。最近,有研究人员描述了真实世界中5GPE-SLIT的治疗情况。研究包括了280名成年人和203名儿童。处方信息包括了82.5%的成年人和86.7%的儿童。研究人员对所有的患者进行了皮刺测试。

Allergy Asthma Immunol Res:屋尘螨敏感的老年人鼻炎患者中,舌下免疫治疗的效果和安全性评估

最近,有研究人员确定了屋尘螨(HDM)舌下免疫治疗(SLIT)在患有AR的老年人患者中治疗的效果和安全性。研究包括了45名年龄不小于60岁的HDM诱导的AR患者,并分为2个小组,分别为SLIT治疗组(n=30)和对照组(n=15)。研究发现,在人口统计特征,鼻黏膜总症状得分(STSS),皮肤对HDMs的反应或者对HDMs的血清总的/特异的lgE水平在2个小组之间均没有显著额差异。在第1年,2个小组

Medicine (Baltimore):针灸在过敏性鼻炎患者中的治疗效果研究

最近,有研究人员在舌下特异性过敏原免疫治疗(SASIT)的过敏性鼻炎(AR)患者中,回顾性的分析了针灸疗法作为一种附加的疗法(AAOT)对过敏性鼻炎患者的治疗效果。研究总共包括了120名符合研究标准的AR成年人患者。其中60名患者接受了AAOT和SASIT治疗,并作为治疗组,其他60名受试者只接受了SASIT治疗,并作为对照组。主要结果为AR症状,次级结果为通过鼻炎生活质量调查问卷(RQLQ)评估

Immunotherapy:马齿苋库提取物舌下免疫治疗耐受性和阳性治疗效果研究

最近,有研究人员评估了马齿苋库提取物舌下免疫治疗在患有过敏性鼻窦炎患者的耐受性和治疗效果。研究包括了51名患者,并且进行马齿苋库提取物舌下免疫治疗(6次增加剂量),并且每月对治疗进行调查。研究发现,470给药剂量下,只有3.8%的患者消除了系统性反应(1.5%的非特异性,2.3%的为等级1)。考虑到研究的治疗效果参数,研究人员发现,最后一次的皮肤反应和基线时间点测量的皮肤反应相比,具有显著的降低,

Allergol Int:在季节过敏性鼻炎中,全唾液在舌下免疫治疗效果中的作用研究

开发能够预测舌下免疫治疗(SLIT)治疗过敏性疾病临床效果的方法是一个非常关键的问题。全唾液作为SLIT治疗中与过敏原提取物首先接触的组分,最近,有研究人员在日本柳杉花粉过敏症中,探究了是否全唾液与SLIT的临床效果相关。研究人员将血液单核细胞或者单核THP-1细胞培养在含有或者不含油全唾液或者纯唾液的培养基中,并且还包括或者不包括唾液过滤和TLR2和/或TLR4信号的阻断处理。研究发现,单核细胞